Birgit Lorenz
About
In The Last Decade
Birgit Lorenz
236 papers receiving 6.6k citations
Peers
Comparison fields: 5 of 139
- Molecular Biology 4.8k
- Ophthalmology 3.0k
- Radiology, Nuclear Medicine and Imaging 1.6k
- Genetics 1.1k
- Cellular and Molecular Neuroscience 916
Countries citing papers authored by Birgit Lorenz
This map shows the geographic impact of Birgit Lorenz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Lorenz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Lorenz more than expected).
Fields of papers citing papers by Birgit Lorenz
This network shows the impact of papers produced by Birgit Lorenz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Lorenz. The network helps show where Birgit Lorenz may publish in the future.
Co-authorship network of co-authors of Birgit Lorenz
This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Lorenz. A scholar is included among the top collaborators of Birgit Lorenz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Lorenz. Birgit Lorenz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 5 | |
| 7 | 6 | |
| 8 | 18 | |
| 9 | High-coverage next-generation sequencing (NGS) for retinal dystrophies and Usher syndrome: High diagnostic yield, CNV detection, novel disease mechanisms and therapy targets | 1 |
| 10 | 23 | |
| 11 | Gene therapy for vision loss -- recent developments. | 20 |
| 12 | Genetische und klinische Heterogenität bei LCA-Patienten: Das Ende der Einheitlichkeit | 1 |
| 13 | Functional Analysis of AIPL1 Mutations and Splice Variants | 0 |
| 14 | Variation of Phenotype in Patients With Compound Heterozygous Mutations of RetGC1 Depending on the Affected Domains | 2 |
| 15 | Fundus Autofluorescence in Carriers for Choroideremia | 2 |
| 16 | Alternative Splicing of LCA Gene AIPL1 Is Conserved in Mammals | 0 |
| 17 | Alternative Splicing in AIPL1 – Implications On Function And The Mutational Spectrum | 0 |
| 18 | BIGH3 mutation spectrum in corneal dystrophies. | 178 |
| 19 | Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. | 214 |
| 20 | Early-onset severe rod-cone dystrophy in young children with RPE65 mutations. | 158 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.